An interventional study of serratus intercostal plane block as analgesic technique in Postoperative Pain, sponsored by Hospital del Rio Hortega. Active, not recruiting at 1 site in Spain. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-09-25.
Sponsored by Hospital del Rio Hortega · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 86 studies in Pain, Postoperative with a site in Spain — 18 open to participants now, 23 under way, 1 of them phase 3. Pain, Postoperative · Spain.
Among the 86 studies in Pain, Postoperative with a site in Spain, this one is the 21st largest by planned enrollment of the 60 interventional ones that give a count, is one of 6 that started in 2025, is one of 30 with no phase, reaches primary completion later than 17 of the 22 other live ones, and was the 75th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →18 of the 86 studies in Pain, Postoperative with a site in Spain are open now. Recruiting first, the newest first:
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+ · Healthy volunteers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Sites in Spain
Ages 18+
Fundacin Biomedica Galicia Sur · Sites in Spain
Ages 18+ · Healthy volunteers
Hospital Central de la Defensa Gómez Ulla · Sites in Spain
Ages 18+
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
86 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 13 · Phase 4 14
First in 2001; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 128 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 60 interventional studies, 106 across the 26 observational. Of the 55 that completed or were terminated, 8 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 86 have an industry lead sponsor. The 10 most frequent:
Hospital del Rio Hortega is the lead sponsor of 27 studies on the registry; 7 are open to participants now.
Hospital del Rio Hortega has 1 study filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
5 of the studies in Pain, Postoperative with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07193472Hospital del Rio HortegaSerratus Intercostal Plane Block Versus Port Infiltration in Laparoscopic Cholecystectomy | 2026-12-31 |
| NCT06638437University Rovira i VirgiliPrevention of Postsurgical Chronic Pain in Children and Adolescents (PREVENDOL) | 2027-06-30 |
| NCT07943299Cardenal Herrera UniversityPatient Experience Across Dental Implant Drilling Protocols | 2027-07 |
| NCT07377370Universitat Internacional de CatalunyaFactors Influencing Postoperative Pain After Gingival Graft Harvesting | 2027-07 |
| NCT05920382Consorci Sanitari de l'Alt Penedès i GarrafRadiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain. | 2027-09-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 86 studies in Pain, Postoperative with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Most patients undergoing laparoscopic cholecystectomy (LC) experience moderate to severe pain in the first 24 hours after surgery. Port infiltration is the usual analgesic method while serratus-intercostal plane blockade (SIPB) has shown its efficacy in open cholecystectomy pain control. The aim of the present study was to compare the efficacy of both techniques in pain control.
OBJECTIVE The prospective randomised study has the working hypothesis is based on evaluating whether serratus-intercostal block (modified BRILMA) is equal or superior to laparoscopic port infiltration (PI) in terms of quality of postoperative recovery and pain control.
Secondary objectives of the study will be to assess the absence of adverse effects.
MATERIAL AND METHODS the investigators present a low-intervention clinical trial. The sample will be composed of 128 patients divided into two groups according to the analgesic technique (serratus-intercostal and port infiltration), following a 1:1 randomisation, consecutively until the sample size is reached and fulfilling the following criteria: signature of informed consent, over 18 years of age, ASA I-III, undergoing laparoscopic cholecystectomy.
Intraoperatively, patients will receive standard monitoring and induction. Analgesia will consist of a multimodal strategy (8 mg dexamethasone, 1 g paracetamol and 50 mg dexketoprofen pre-incisionally, intraoperative fentanyl on demand and the corresponding regional technique).
In the postoperative period, the main variable to be evaluated in forms designed for this purpose will be the difference in pain assessed by means of an numeric rating scale (NRS scale) and the quality of recovery will be measured by means of the modified Postoperative Quality of Recovery Score (QoR-15 ) recovery scale (15 responses).
Background
Postoperative pain remains a significant concern following laparoscopic cholecystectomy (LC), with most patients experiencing moderate to severe pain within the first 24 hours. Traditionally, port-site infiltration (PI) with local anesthetics is employed for analgesia. However, the serratus-intercostal plane block (SIPB), also known as the modified BRILMA block, has demonstrated efficacy in pain management for open cholecystectomy. Its role in LC remains to be clarified.
Objective
The primary objective of this prospective randomised study is to evaluate whether SIPB (modified BRILMA block) provides equivalent or superior postoperative analgesia and quality of recovery compared to port-site infiltration in patients undergoing LC.
Secondary objective: To assess the incidence of adverse effects related to each analgesic technique.
Methods
This study is designed as a low-intervention, prospective, randomized clinical trial. A total of 128 adult patients (ASA I-III) scheduled for elective laparoscopic cholecystectomy will be randomly allocated (1:1) to receive either serratus-intercostal plane block or laparoscopic port infiltration for perioperative analgesia. Randomization will be performed consecutively until the target sample size is reached.
Inclusion Criteria:
Age ≥ 18 years
ASA physical status I-III
Informed consent provided
Exclusion Criteria:
(Coagulopaty, allergy to local anaesthetic, history of chronic pain)
Intraoperative Management:
All patients will receive standardized general anesthesia and multimodal analgesia comprising:
8 mg dexamethasone
1 g paracetamol
50 mg dexketoprofen (administered pre-incisionally)
Fentanyl as needed during surgery
Assigned regional analgesic technique (SIPB or PI)
Postoperative Evaluation:
Primary Outcome Measures:
Pain intensity using the Numerical Rating Scale (NRS) at predefined intervals
Quality of recovery assessed via the modified QoR-15 questionnaire
Secondary Outcome Measure:Incidence of adverse events or complications related to the analgesic techniques
SIPB group: receive The Serratus intercostal plane block as analgesic technique after induction. With the patient lying in supine position, the local anaesthetic is administered in the plane under Serratus muscle at the 8th rib level Infiltration group: in this group the surgeons administered local anaesthetic after inserting the trocar.
Conclusion (anticipated)
This trial aims to determine whether SIPB offers superior analgesic efficacy and recovery quality compared to standard port infiltration in LC, potentially informing improved postoperative pain protocols.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
patients receiving port infiltration as analgesia
Procedure: serratus intercostal plane block as analgesic technique
the SIPB will be applied after starting surgery and before general anaesthesia
efectiveness of analgesia (SIPB versus IP)
The working hypothesis is based on evaluating whether serratus-intercostal block (modified BRILMA) is equal or superior to laparoscopic port infiltration (PI) in terms of quality of postoperative recovery (QoR15) and pain control (NRS) 0-10
Time frame: one year
side efects
assesment of side efects
Time frame: one year
Postoperative pain control
Pain developed for patients after surgery first 24 h . nRS 0-10
Time frame: One year
Postoperative recovery
Intake, rest at night, walking…assessed with QoR15 0- 150
Time frame: One year
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Jun 2025 (actual). Primary completion is estimated for Dec 2026, 18 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 18 months is above that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 25, 2026: primary completion Dec 2025 → Dec 2026 and completion Dec 2025 → Dec 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital del Rio Hortega